TNFSF11 and osteoporosis: Given that coexistence of osteoporosis and sarcopenia is prevalent in the elderly population, the potential benefit of anti-RANKL treatment in possibly mitigating skeletal muscle atrophy while enhancing bone mechanical properties should be further investigated.